著者名,論文名,雑誌名,ISSN,出版者名,出版日付,巻,号,ページ,URL,URL(DOI)
Luis G. Paz-Ares and Suresh S. Ramalingam and Tudor-Eliade Ciuleanu and Jong-Seok Lee and Laszlo Urban and Reyes Bernabe Caro and Keunchil Park and Hiroshi Sakai and Yuichiro Ohe and Makoto Nishio and Clarisse Audigier-Valette and Jacobus A. Burgers and Adam Pluzanski and Randeep Sangha and Carlos Gallardo and Masayuki Takeda and Helena Linardou and Lorena Lupinacci and Ki Hyeong Lee and Claudia Caserta and Mariano Provencio and Enric Carcereny and Gregory A. Otterson and Michael Schenker and Bogdan Zurawski and Aurelia Alexandru and Alain Vergnenegre and Judith Raimbourg and Kynan Feeney and Sang-We Kim and Hossein Borghaei and Kenneth John O'Byrne and Matthew D. Hellmann and Arteid Memaj and Faith Ellen Nathan and Judith Bushong and Phuong Tran and Julie R. Brahmer and Martin Reck,"First-Line Nivolumab Plus Ipilimumab in Advanced NSCLC: 4-Year Outcomes From the Randomized, Open-Label, Phase 3 CheckMate 227 Part 1 Trial",Journal of Thoracic Oncology,1556-0864,Elsevier BV,2022-02,17,2,289-308,https://cir.nii.ac.jp/crid/1360016870546888576,https://doi.org/10.1016/j.jtho.2021.09.010